Alison Hogg

3.2k total citations · 1 hit paper
34 papers, 2.3k citations indexed

About

Alison Hogg is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Alison Hogg has authored 34 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Infectious Diseases. Recurrent topics in Alison Hogg's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (5 papers) and Immune responses and vaccinations (4 papers). Alison Hogg is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (5 papers) and Immune responses and vaccinations (4 papers). Alison Hogg collaborates with scholars based in United States, New Zealand and United Kingdom. Alison Hogg's co-authors include Darius Babusis, John J. Won, Alexandra Schäfer, Danielle Porter, Amy Sims, Robert Jordan, Timothy P. Sheahan, Mark R. Denison, Scott Sellers and Tomáš Cihlář and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Alison Hogg

34 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

2020 1.2k citations Timothy P. Sheahan, Amy Sims et al. Nature Communications profile →

Peers

Countries citing papers authored by Alison Hogg

Since Specialization

Citations

This map shows the geographic impact of Alison Hogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Hogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Hogg more than expected).

Fields of papers citing papers by Alison Hogg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Hogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Hogg. The network helps show where Alison Hogg may publish in the future.

Co-authorship network of co-authors of Alison Hogg

This figure shows the co-authorship network connecting the top 25 collaborators of Alison Hogg. A scholar is included among the top collaborators of Alison Hogg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Hogg. Alison Hogg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV breakdown → 2020 ·Nature Communications ·Timothy P. Sheahan, Amy Sims, Sarah R. Leist, Alexandra Schäfer, John J. Won, Ariane J. Brown, Stephanie A. Montgomery, Alison Hogg, Darius Babusis, Michael O. Clarke, (unknown), Laura Bauer, Scott Sellers, Danielle Porter, Joy Y. Feng, Tomáš Cihlář, Robert Jordan, Mark R. Denison, Ralph S. Baric	1241
2	Role of CD4 T cell helper subsets in immune response and deviation of CD8 T cells in mice* 2017 ·European Journal of Immunology ·Alison Hogg, Yongjun Sui, Shlomo Z. Ben‐Sasson, William E. Paul, Jay A. Berzofsky	7
3	Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis 2016 ·PLoS ONE ·Timothy Lahey, Dominick J. Laddy, (unknown), (unknown), Alison Hogg, James Keeble, (unknown), Mei Mei Ho, Robert D. Arbeit, C. Fordham von Reyn	41
4	Early SIV Dissemination After Intrarectal SIVmac251 Challenge Was Associated With Proliferating Virus-Susceptible Cells in the Colorectum 2015 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Yongjun Sui, Eun Mi Lee, Yichuan Wang, Alison Hogg, Blake Frey, David Venzon, Ranajit Pal, Jay A. Berzofsky	7
5	Vaginal type-II mucosa is an inductive site for primary CD8+ T-cell mucosal immunity 2015 ·Nature Communications ·Yichuan Wang, Yongjun Sui, Shingo Kato, Alison Hogg, Jason C. Steel, John C. Morris, Jay A. Berzofsky	19
6	Exploring the use of tablets (iPads) with children and young adults with disabilities in Trinidad 2014 ·Disability and Rehabilitation Assistive Technology ·(unknown), Debra Cameron, Sonia Gulati, Alison Hogg	12
7	Immune targeting of PD-1hi expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques 2013 ·Virology ·Diego A. Vargas‐Inchaustegui, Peng Xiao, Alison Hogg, Thorsten Demberg, Katherine McKinnon, David Venzon, Egidio Brocca‐Cofano, (unknown), (unknown), Lauren Hudacik, Ranajit Pal, Yongjun Sui, Jay A. Berzofsky, Linda Liu, Solomon Langermann, Marjorie Robert-Guroff	14
8	TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4+ memory T cell loss in SIVmac251-challenged rhesus macaques 2011 ·Vaccine ·Yongjun Sui, Susan J. Gagnon, Amiran Dzutsev, Qing Zhu, Huifeng Yu, Alison Hogg, Yichuan Wang, (unknown), Igor M. Belyakov, David Venzon, Dennis M. Klinman, Warren Strober, Brian L. Kelsall, Genoveffa Franchini, Jay A. Berzofsky	16
9	Activation of NK cell granulysin by mycobacteria and IL-15 is differentially affected by HIV 2011 ·Tuberculosis ·Alison Hogg, Matthew B. Huante, (unknown), Jessica Williams, Monique R. Ferguson, Miles W. Cloyd, Evans Amukoye, Janice J. Endsley	6
10	Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors 2010 ·Clinical Cancer Research ·Kevin O. Hicks, Bronwyn G. Siim, Jagdish K. Jaiswal, Frederik B. Pruijn, (unknown), (unknown), Alison Hogg, H.D. Sarath Liyanage, Mary J. Dorie, Jeremy Brown, William A. Denny, Michael P. Hay, William R. Wilson	103
11	Characterization of age-related changes in bovine CD8+ T-cells 2010 ·Veterinary Immunology and Immunopathology ·Alison Hogg, K.R. Parsons, Geraldine Taylor, Andrew Worth, Peter C. L. Beverley, Christopher J. Howard, Bernardo Villarreal‐Ramos	15
12	CXCL10 Production by Human Monocytes in Response to Leishmania braziliensis Infection 2009 ·Infection and Immunity ·Diego A. Vargas‐Inchaustegui, Alison Hogg, Gianfranco Tulliano, Alejandro Llanos‐Cuentas, Jorge Arévalo, Janice J. Endsley, Lynn Soong	51
13	Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours 2009 ·British Journal of Cancer ·Dahat A. Hussein, Sarah V. Holt, (unknown), Tetyana Klymenko, (unknown), Alison Hogg, EJ Estlin, Timothy H. Ward, Caroline Dive, Guy Makin	12
14	The antigen-specific memory CD8+ T-cell response induced by BCG in cattle resides in the CD8+γ/δTCR−CD45RO+ T-cell population 2008 ·Vaccine ·Alison Hogg, Andrew Worth, Peter C. L. Beverley, Christopher J. Howard, Bernardo Villarreal‐Ramos	22
15	The calf model of immunity for development of a vaccine against tuberculosis 2008 ·Veterinary Immunology and Immunopathology ·Janice J. Endsley, W. Ray Waters, Mitchell V. Palmer, Brian J. Nonnecke, Tyler C. Thacker, William R. Jacobs, Michelle H. Larsen, Alison Hogg, (unknown), (unknown), (unknown), Tracey J. Coffey, Chris Howard, (unknown), D. Mark Estes	23
16	Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells 2007 ·Neoplasia ·Jane Barraclough, Cassandra L. Hodgkinson, Alison Hogg, Caroline Dive, Arkadiusz Welman	28
17	Mycobacterium bovis BCG vaccination induces memory CD4+ T cells characterized by effector biomarker expression and anti-mycobacterial activity 2007 ·Vaccine ·Janice J. Endsley, Alison Hogg, (unknown), Martin McAulay, Tracey J. Coffey, Chris Howard, (unknown), W. Ray Waters, Brian J. Nonnecke, D. Mark Estes, Bernardo Villarreal‐Ramos	27
18	In Vitro and In Vivo Models for Evaluation of GDEPT: Quantifying Bystander Killing in Cell Cultures and Tumors 2004 ·Humana Press eBooks ·William R. Wilson, Susan M. Pullen, Alison Hogg, Stephen M. Hobbs, Frederik B. Pruijn, Kevin O. Hicks	17
19	Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures. 2002 ·PubMed ·William R. Wilson, Susan M. Pullen, Alison Hogg, Nuala A. Helsby, Kevin O. Hicks, William A. Denny	59
20	The effect of Terramycin/LA in combination with a Bordetella/Pasteurella vaccine in controlling atrophic rhinitis in swine. 1990 ·Z. Pejsak, Alison Hogg, (unknown), (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact